SRDX Share Price

Open 24.55 Change Price %
High 24.70 1 Day -0.20 -0.81
Low 24.35 1 Week -0.50 -2.01
Close 24.40 1 Month -1.25 -4.87
Volume 50083 1 Year 6.36 35.25
52 Week High 30.75
52 Week Low 17.45
SRDX Important Levels
Resistance 2 24.72
Resistance 1 24.59
Pivot 24.48
Support 1 24.21
Support 2 24.08
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

SurModics, Inc. (NASDAQ: SRDX)

SRDX Technical Analysis 2
As on 20th Jan 2017 SRDX Share Price closed @ 24.40 and we RECOMMEND Buy for LONG-TERM with Stoploss of 24.38 & Strong Sell for SHORT-TERM with Stoploss of 25.30 we also expect STOCK to react on Following IMPORTANT LEVELS.
SRDX Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
SRDX Other Details
Segment EQ
Market Capital 332110880.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.surmodics.com
SRDX Address
SRDX
9924 West 74th Street
Eden Prairie, MN 55344
United States
Phone: 952-500-7000
Fax: 952-500-7001
SRDX Latest News
Interactive Technical Analysis Chart SurModics, Inc. ( SRDX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on SurModics, Inc.
SRDX Business Profile
SurModics, Inc. (SurModics) is a provider of drug delivery and surface modification technologies to the healthcare industry. The Company has partnered with many of the world�s emerging medical device, pharmaceutical and life science companies to develop and commercialize products designed to improve patient outcomes. Its offerings include drug delivery technologies (coatings, microparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility characteristics, and components for in vitro diagnostic test kits and microarrays. It has three business units: Medical Device, Pharmaceuticals, and In Vitro Diagnostics. As of September 30, 2010, it had 102 licensed product classes (customer products utilizing SurModics technology) already on the market generating royalties and 110 customer product. In November 2011, the Company sold SurModics Pharmaceuticals assets to Evonik Industries AG.